Ikris Pharma Network

NPS (Named Patient Service)

We help doctors and hospitals legally access life-saving medicines not yet approved or available in India. Every step follows CDSCO and DGFT regulations, ensuring authentic, safe, and compliant delivery of therapies to patients in need. (Know More) In many cases, breakthrough medicines are launched globally but are still unavailable in India due to regulatory timelines. For patients fighting cancer, rare diseases, or other critical conditions, waiting is not an option. To bridge this gap, we provides a trusted Named Patient Import Service (NPI), enabling legal and compliant access to unapproved or unavailable medicines. How We Help Patients Doctor-Led Process: Access begins with a prescription and a medical justification from the treating physician. Regulatory Guidance: Our experts assist with CDSCO approvals, DGFT import permits, and Form 12A/12B submissions. End-to-End Handling: From import licenses and customs clearance to temperature-controlled logistics, we ensure a seamless process. Authenticity Guaranteed: Every medicine is sourced only from licensed manufacturers or their authorized distributors, eliminating the risk of counterfeits.

Why It Matters: Patients with rare and life-threatening conditions often cannot afford delays in treatment. The NPI route provides a lifeline, offering access to therapies that might otherwise take years to become locally available. With us, patients and healthcare providers get a reliable partner who understands the urgency, the regulations, and the sensitivity of these cases. Our Commitments Compliance First: 100% adherence to CDSCO and DGFT regulations. Safety & Transparency: Robust pharmacovigilance, ABAC compliance, and full cost transparency. Cold-Chain Excellence: WHO-GDP certified warehouses in Belgium & Bulgaria and certified couriers maintain the integrity of biologics and specialty drugs. Global Network: Access to therapies from leading pharma innovators across the US, EU, and other regulated markets. Our mission is simple yet powerful — no patient should be denied treatment because a medicine is not locally available. Through our Named Patient Import Service, we transform possibilities into access, and access into care.